Coyote Bioscience is dedicated to innovation in portable point-of-care molecular diagnostics, pathogen detection and life science tools. They produce portable RT-PCR instruments, and ground-breaking reagents for molecular diagnostics.
In 2013, Coyote Bioscience developed its break-through one-step molecular diagnostic method, “DirectDetect”, based on direct qPCR, which does not require nucleic acid extraction.
In 2020, Coyote Bioscience used this technology to develop the DirectDetect COVID-19 qPCR Kit, a fast, sensitive and accurate qPCR kit for the rapid detection of the SARS-CoV-2 virus without RNA extraction. The kit uses a streamlined workflow for high throughput testing in central labs or large hospitals. A result can be generated in 90 mins, and RNA extraction kits (a frequent bottleneck in the covid workflow) are not required.